Early Detection & Screening

Early detection and screening is essential to ensure that an individual’s cancer is detected as early as possible and they are therefore provided with the most effective and appropriate treatment. Until we can fully prevent breast cancer through gene research, drug research and diet and lifestyle, we will continue to screen and highlight methods of detecting breast cancer earlier.

Our team is currently investigating new methods of imaging the breast tissue in order to obtain earlier diagnosis of cancer and pre-cancer changes, such as 3D mammography, and breast density measurement. These projects are

  • FHTomo – Using 3D Mammography in younger women to analyse accuracy

Under the leadership of our radiology team, we are conducting clinical trials of new methods of breast screening, and we hope this will convert into improved clinical practice over the next five years. We are also supporting projects into improving breast screening and breast awareness within minority ethnic communities.

Dr Gillian Farnie is investigating the condition of ductal carcinoma in situ (DCIS). This pre-cancer condition, if left untreated, can progress to breast cancer. She is supported in this work by a clinical research team, and by Clinician Scientist In Surgical Oncology and Consultant Oncoplastic Breast Surgeon, Cliona Kirwan.